-+ 0.00%
-+ 0.00%
-+ 0.00%
Voronoi Updates Filing to Report Taiwan Trial Amendment Application for VRN110755
Share
Listen to the news
Voronoi Updates Filing to Report Taiwan Trial Amendment Application for VRN110755
  • Voronoi issued a correction on Nov. 18, 2026, disclosing a Taiwan protocol amendment filing for its VRN110755 Phase 1/2 trial.
  • The application, submitted to Taiwan’s Food and Drug Administration on Nov. 17, covers the trial in EGFR-mutant non-small cell lung cancer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Voronoi Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261118900433), on November 18, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending